The biotechnology sector in the country has played a significant role in enhancing India’s global profile. India stands among the top 12 biotech destinations in the world and ranks third in the Asia Pacific, with approximately 3% share in the global biotechnology industry. The Biotechnology industry in India, comprising about 800 companies, assumes a critical role in the Indian economy. Biopharma is the largest sector contributing about 62 per cent of the total revenue followed by bio-services (18 per cent), bio-agri (15 per cent), bio-industry (4 per cent), and bio-informatics contributing (1 per cent).
By 2020, bio-incubation space of 175,000 sq. ft. has been planned with the target to support 50 world class bio-incubators. By 2025, Indian Biotechnology industry is expected to reach $100 bn.
100% FDI for biotechnology sector is allowed under the automatic route for green-field pharma.
100% FDI in biotechnology is allowed under the government route for brownfield pharma in up to 74% FDI is under automatic route and beyond 74% is under the government approval route.
Up to 100% FDI in biotechnology in India is allowed under the automatic route for the manufacturing of medical devices.
World’s largest producer of recombinant Hepatitis B vaccine
World’s largest 2-wheeler and 3-wheeler manufacturer
World’s 3rd largest heavy truck manufacturer and 4th largest car manufacturer
The sector is divided into five major segments- Bio-pharma, Bio-services, Bio-agri, Bio-industrial, and Bio-informatics
The biopharmaceutical sector accounts for the largest share of the biotech industry with a share of 64% of total revenues, followed by bio-services with 18% market share
India is becoming a leading destination for clinical trials, contract research, and manufacturing activities, which is further fuelling the growth of the bio-services sector
Bio-agri segments accounted for 14% of the biotech industry in 2015-16, while the remaining market is catered by bio-industrial (3%) and bio-informatics (1%)
India's Serum Institute is the largest Bio-pharma company in the country and accounts for approximately 22% of the biopharma market
30 bio-incubators and biotech parks have been supported and established during April 2014-September 2016
Budget 2020: Rs. 3,000 Cr kept aside for skill development and Rs. 99,300 Cr for education
Budget 2020: FDI In India Constantly Increasing, Says President Kovind
Will changes in FDI norms lead to more employment??
Policy Watch - Review of FDI Policy - FDI India
India Received Highest-Ever FDI Of Over $64 Billion In 2018-19